Stimulation of Erythrocyte Cell Membrane Scrambling by Mitotane
Author(s) -
Janin Jacobi,
Elisabeth Lang,
Rosi Bissinger,
Leonie Frauenfeld,
Paola Modicano,
Caterina Faggio,
Majed Abed,
Florian Läng
Publication year - 2014
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000358715
Subject(s) - phosphatidylserine , apoptosis , mitotane , ionomycin , annexin , chemistry , extracellular , annexin a5 , endocrinology , medicine , cell , programmed cell death , biophysics , cytosol , microbiology and biotechnology , stimulation , biology , biochemistry , membrane , phospholipid , adrenocortical carcinoma , enzyme
background: Mitotane (1,1-dichloro-2-[o-chlorophenyl]-2-[p-chlorophenyl]ethane), a cytostatic drug used for the treatment of adrenocortical carcinomas, is effective by triggering tumor cell apoptosis. In analogy to apoptosis of nucleated cells, eryptosis is the suicidal death of erythrocytes, which is typically paralleled by cell shrinkage and breakdown of cell membrane phosphatidylserine asymmetry with subsequent phosphatidylserine exposure at the erythrocyte surface. Eryptosis may be triggered by increase of cytosolic Ca(2+) concentration ([Ca(2+)]i). The present study tested, whether treatment of human erythrocytes with mitotane is followed by eryptosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom